Xepa Pharmaceutical Private Limited - Company Profile

It is a pharma private limited company based in Thane, Maharashtra, India, established in 2020.
2020 Thane, Maharashtra, India Struck Off
Last Updated:
Access Report
About Xepa Pharmaceutical Private Limited

Xepa Pharmaceutical Private Limited, a struck off private limited company, was established on 03 February 2020 in Thane, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U74999MH2020PTC337058. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Bina Kumari (Director), Neha Gupta (Director), Pratima Kumari (Director). It is based at Flat No.101,Shivshrishti Apartment A Wing,Plot No.52/53,Ambernath-(East), Thane, Maharashtra, 421501.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74999MH2020PTC337058

  • Registration Number

    337058

  • Incorporation Date

    03 February 2020

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 6 Year, 8 Days
Company report

Xepa Pharmaceutical Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Xepa Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Xepa Pharmaceutical Private Limited?
Current Directors
Name Designation Appointment Date Status
Bina Kumari Director 03 Feb 2020 Current
Neha Gupta Director 03 Feb 2020 Current
Pratima Kumari Director 03 Feb 2020 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Xepa Pharmaceutical.

Enhance accessibility to Xepa Pharmaceutical's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Xepa Pharmaceutical revenue growth over time
Xepa Pharmaceutical profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Xepa Pharmaceutical?

Unlock access to Xepa Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Xepa Pharmaceutical?

Unlock and access historical data on people associated with Xepa Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Xepa Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Xepa Pharmaceutical's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Xepa Pharmaceutical
Recent Activity within the Organization
  • Director Appointment

    Progress on Bina Kumari was appointed as a Director was appointed as a Director on 03 Feb 2020 & has been associated with this company since 6 years 8 days . was documented.

  • Director Appointment

    Neha Gupta was appointed as a Director was appointed as a Director on 03 Feb 2020 & has been associated with this company since 6 years 8 days . was recorded as a recent event.

  • Director Appointment

    Pratima Kumari was appointed as a Director was appointed as a Director on 03 Feb 2020 & has been associated with this company since 6 years 8 days . was recorded as a recent event.

  • Company Incorporation

    Progress on Xepa Pharmaceutical Private Limited was registered on 03 Feb 2020 with Roc Mumbai & aged 6 years 8 days as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Xepa Pharmaceutical Private Limited?

The CIN of Xepa Pharmaceutical Private Limited is U74999MH2020PTC337058.

Where is Xepa Pharmaceutical Private Limited headquartered?

Xepa Pharmaceutical Private Limited is headquartered at Flat No.101,Shivshrishti Apartment A Wing,Plot No.52/53,Ambernath-(East), Thane, Maharashtra, 421501.

When was Xepa Pharmaceutical Private Limited incorporated?

Xepa Pharmaceutical Private Limited was incorporated on 03 February 2020.

Who are the current directors of Xepa Pharmaceutical Private Limited?

The current directors of Xepa Pharmaceutical Private Limited are

What is the primary industry of Xepa Pharmaceutical Private Limited?

The primary industry of Xepa Pharmaceutical Private Limited is Pharma.

Is Xepa Pharmaceutical Private Limited a listed company?

Xepa Pharmaceutical Private Limited is unlisted.

What is the capital structure of Xepa Pharmaceutical Private Limited?

The authorized capital of Xepa Pharmaceutical Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available